AndrewSaxonMD

Executive Director, Food and Drug Allergy Care Center; Physician, Clinical Immunology and Allergy; Professor Emeritus, Medicine; Clinical Immunology and Allergy, UCLA School of Medicine

Join to view full profile

Dr. Saxon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Saxon's full profile

Already have an account?

Office
UCLA Medical Ctr
10833 LeConte Ave
Los Angeles, CA 90095
Phone+1 310-367-9736
Is this information wrong?

Education & Training

Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1972 - 1975
Harvard Medical SchoolClass of 1972

Certifications & Licensure

CA State Medical License 1973 - 2026
American Board of Allergy and Immunology Allergy & Immunology
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Diagnostic Laboratory Immunology

Awards, Honors, & Recognition

Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
Super Doctor SuperDoctors.com

Clinical Trials

Onsite Versus Referral Models of Primary Care for Substance Abusing Patients
Completed
Not Applicable
Prazosin Alcohol Dependence IVR Study Start of enrollment: 2005 Sep 01
Completed
Phase 4
Starting Treatment With Agonist Replacement Therapies (START) Start of enrollment: 2006 Apr 01
Completed
Phase 4

Publications & Presentations

PubMed

2 citations
Elevated customary alcohol consumption attenuates opioid effects.
Monique M. Cherrier, Danny D. Shen, Laura M. Shireman, Andrew J. Saxon, Tracy L. Simpson, Alex Men, Preetma Kooner, Gregory W. Terman> ;Pharmacology, Biochemistry, and Behavior. 2021 Nov 4
13 citations
Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems.
Sarah M. Bagley, Laura J. Chavez, Jordan M. Braciszewski, Mary Akolsile, Denise M. Boudreau, Gwen T. Lapham, Cynthia I. Campbell, Gavin Bart, Bobbi Jo H. Yarborough, J...> ;Addiction Science & Clinical Practice. 2021 Jul 7
59 citations
High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder.
Andrew A. Herring, Erik Anderson, Xiwen Zhao, James Dziura, Kathryn Hawk, Ryan P. McCormack, Andrew J. Saxon, Gail D'Onofrio, Luftig, J., Joshua Luftig, Aidan A. Vosooghi> ;JAMA Network Open. 2021 Jul 1
41 citations
Correlates of Long-Term Opioid Abstinence After Randomization to Methadone Versus Buprenorphine/Naloxone in a Multi-Site Trial.
Yuhui Zhu, Elizabeth Evans, Larissa J. Mooney, Andrew J. Saxon, Annamarie Kelleghan, Caroline Yoo, Yih-Ing Hser> ;Journal of Neuroimmune Pharmacology. 2018 Aug 9
4 citations
Blocking Allergic Reaction through Targeting Surface-Bound IgE with Low-Affinity Anti-IgE Antibodies.
Ke Zhang, Jeffrey Liu, Thao Truong, Elyssa Zukin, Wendy Chen, Andrew Saxon> ;Journal of Immunology. 2017 May 15
108 citations
Chronic pain among patients with opioid use disorder: Results from electronic health records data.
Hser, Y. I., Hser, Y. I., Mooney, L. J., Mooney, L. J., Saxon, A. J., Saxon, A. J., Miotto, K., Miotto, K., Bell, D. S., Bell, D. S., Huang, D., Huang, D.> ;Journal of substance abuse treatment.
60 citations
A narrative review: The effects of opioids on sleep disordered breathing in chronic pain patients and methadone maintained patients.
Sameer Hassamal, Karen Miotto, Tisha Wang, Andrew J. Saxon> ;The American Journal on Addictions. 2016 Sep 1
43 citations
BuprenorphineÂ +Â naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study.
Ling, W., Ling, W., Hillhouse, M. P., Hillhouse, M. P., Saxon, A. J., Saxon, A. J., Mooney, L. J., Mooney, L. J., Thomas, C. M., Thomas, C. M., Ang, A., Ang, A., Matth...> ;Addiction (Abingdon, England).
9 citations
Enhanced Prophylactic and Therapeutic Effects of Polylysine-Modified Ara h 2 DNA Vaccine in a Mouse Model of Peanut Allergy
Zhenlai Zhu, Jinlei Yu, Yuan Niu, Shuhong Sun, Yufeng Liu, Andrew Saxon, Ke Zhang, Wei Li> ;International Archives of Allergy and Immunology. 2016 Jan 1
2 citations
CSF TNFα Has Not Been Shown to be Elevated in Headache Patients.
Andrew Saxon> ;Headache. 2015 Oct 1
1 citations
Authors' reply: "Risk reduction with buprenorphine-naloxone and methadone: patient's choice".
G E Woody, Douglas Bruce, Philip T. Korthuis, Sumedha Chhatre, Maureen Hillhouse, Petra Jacobs, James L. Sorensen, Andrew J. Saxon, Sabrina Poole, David S. Metzger, Wa...> ;Journal of Acquired Immune Deficiency Syndromes. 2014 Dec 15
Tobacco use trajectories among a large cohort of treated smokers with posttraumatic stress disorder.
Malte, C. A.,Dennis, P. A.,Saxon, A. J.,McFall, M.,Carmody, T. P.,Unger, W.,Beckham, J. C.> ;Addict Behav. 2014 Dec 03
Use of a learning collaborative to support implementation of integrated care for smoking cessation for veterans with posttraumatic stress disorder.
Ebert, L.,Malte, C.,Hamlett-Berry, K.,Beckham, J.,McFall, M.,Saxon, A.> ;Am J Public Health. 2014 Sep 11
Extended-release Naltrexone and Harm Reduction Counseling For Chronically Homeless People with Alcohol Dependence.
Collins, S. E.,Duncan, M. H.,Smart, B. F.,Saxon, A. J.,Malone, D. K.,Jackson, T. R.,Ries, R. K.> ;Subst Abus. 2014 May 02
Clinical monitoring and high-risk conditions among patients with SUD newly prescribed opioids and benzodiazepines.
Grossbard, J. R.,Malte, C. A.,Saxon, A. J.,Hawkins, E. J.> ;Drug Alcohol Depend. 2014 Jun 28
Longitudinal analysis of the relationship between PTSD symptom clusters, cigarette use, and physical health-related quality of life.
Aversa, L. H.,Stoddard, J. A.,Doran, N. M.,Au, S.,Chow, B.,McFall, M.,Saxon, A. J.,Baker, D. G.> ;Qual Life Res. 2013 Aug
Survey of providers' attitudes toward integrating smoking cessation treatment into posttraumatic stress disorder care.
Malte, C. A.,McFall, M.,Chow, B.,Beckham, J. C.,Carmody, T. P.,Saxon, A. J.> ;Psychol Addict Behav. 2013 Mar
Cocaine Use Reduction with Buprenorphine (CURB): Rationale, design, and methodology.
Mooney, L. J., Nielsen, S., Saxon, A., Hillhouse, M., Thomas, C., Hasson, A., Stablein, D., McCormack, J., Lindblad, R., Ling, W.> ;Contemp Clin Trials. 2013 Mar
PTSD and depression as predictors of physical health-related quality of life in tobacco-dependent veterans.
Aversa, L. H., Stoddard, J. A., Doran, N. M., Au, S., Chow, B., McFall, M., Saxon, A., Baker, D. G.> ;J Psychosom Res. 2012 Sep
22 citations
Prevention of oral food allergy sensitization via skin application of food allergen in a mouse model
W. Li, Z. Zhang, Andrew Saxon, Ke Zhang> ;Allergy. 2012 May 1
37 citations
Penicillin allergy: value of including amoxicillin as a determinant in penicillin skin testing.
Erina Lin, Andrew Saxon, Marc A. Riedl> ;International Archives of Allergy and Immunology. 2010 Jan 1
7 citations
IgE-mediated allergen gene vaccine platform targeting human antigen-presenting cells through the high-affinity IgE receptor.
Anne Behnecke, Wei Li, Ling Chen, Andrew Saxon, Ke Zhang> ;The Journal of Allergy and Clinical Immunology. 2009 Jul 1
136 citations
Factors affecting willingness to provide buprenorphine treatment.
Julie Netherland, Michael Botsko, James E. Egan, Andrew J. Saxon, Chinazo O. Cunningham, Ruth Finkelstein, Mark N. Gourevitch, John A. Renner, Nancy L. Sohler, Lynn E....> ;Journal of Substance Abuse Treatment. 2009 Apr 1
161 citations
Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway.
Marc A. Riedl, Andrew Saxon, David Diaz-Sanchez> ;Clinical Immunology. 2009 Mar 1
123 citations
A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence.
Tracy L. Simpson, Andrew J. Saxon, Charles W. Meredith, Carol A. Malte, Brittney McBride, Laura C. Ferguson, Christopher Gross, Kim Hart, Murray A. Raskind> ;Alcoholism, Clinical and Experimental Research. 2009 Feb 1
Join now to see all

Grant Support

Therapeutic And Anti-Inflammatory Effects Of Phase II "Anti-Oxidant" InductionNational Institute Of Allergy And Infectious Diseases2007–2008
Allergy Therapy With Chimeric Human IG ProteinsNational Institute Of Allergy And Infectious Diseases2003–2007
Therapeutic Anti-Inflammatory Phase II "Anti-Oxidant"National Institute Of Allergy And Infectious Diseases2006
Clinical And Fundamental ImmunologyNational Institute Of Allergy And Infectious Diseases1990–2006
Xenobiotics And Allergic InflammationNational Institute Of Allergy And Infectious Diseases2001–2005
Blocking Xenobiotic And Allergen InflammationNational Institute Of Allergy And Infectious Diseases2001–2002
Regulation Of IGE In Health And DiseaseNational Institute Of Allergy And Infectious Diseases1994–2002
Xenobiotics And Allergic InflammationNational Institute Of Allergy And Infectious Diseases1997–2000
Modulation Of The Human IGE Response By XenobioticsNational Institute Of Allergy And Infectious Diseases1997–2000
Chimeric MRNA Templates Drive AIDS B Cell LymphomasNational Cancer Institute1998–1999
Regulation Of B Cell Differentiation In Common Variable Immunodeficiency--Cd40National Cancer Institute1994–1998
Regulation Of IGE In Health And DiseaseNational Institute Of Allergy And Infectious Diseases1997
Core--Scid-Hu Mouse/Human Chimera Core FacilityNational Institute Of Allergy And Infectious Diseases1994–1997
Molecular Regulation Of Allergic Immune InflammationNational Institute Of Allergy And Infectious Diseases1996
Venoglobulin R-S Safety And Efficacy In Primary Immune DeficienciesNational Center For Research Resources1996
Modulation Of The Human IGE Response By Polycyclic Aromatic HydrocarbonsNational Institute Of Allergy And Infectious Diseases1994–1996
Molecular Regulation Of Allergic-Immune InflammationNational Institute Of Allergy And Infectious Diseases1993–1996
Venoglobulin R-S Safety And Efficacy In Subjects With Primary Immune DeficienciesNational Center For Research Resources1995
IrradiatorNational Center For Research Resources1995
Regulation Of Human IGE In Health And DiseaseNational Institute Of Allergy And Infectious Diseases1985–1993
Triatoma Protracta HypersensitivityNational Institute Of Allergy And Infectious Diseases1985
Therapy In Immunodeficiency SymdromesNational Center For Research Resources1985
L.V. Infusion Of Modified Serum Immunoglobulin--Immunodeficiency SyndromeNational Center For Research Resources1985
Immune Reconstitution Following B.M. TransplantationNational Cancer Institute1985
Control Of The Human B Cell Response By Genomic MechanismsNational Cancer Institute1985

Professional Memberships

American Academy of Allergy Asthma and Immunology - AAAAI
Fellow

Hospital Affiliations

Children's Hospital Los AngelesLos Angeles, California